Recently, upregulation of these mitochondrial proteases and chaperones has been detected in AD patients and 3XTgAD preceding amyloid and tau pathology, suggesting that failure of mitochondrial proteostasis concomitant with general mitochondrial dysfunction is an early event in AD progression [83,104]. Here, MAPT is linked to Alzheimer disease.